A latest piece of reports regarding Google’s work on Android for tablets actually drove residence some extent that’s been evident to many individuals for a protracted whereas.
In keeping with Android Authority, Google is about to introduce a brand new badge to its Google Play Retailer that can spotlight apps designed for the bigger screens of tablets (and book-style foldables, clearly).
That is ostensibly constructive information, however for my cash, it speaks much more to Google’s whopping nice failings within the pill house.
Google’s pill blind spot
You would query why it’s taken Google this lengthy to focus on tablet-ready apps in such a basic style – Android tablets have been a factor since 2010, in any case.
However I believe it speaks to a much more basic problem. Why is Google nonetheless scuffling with the break up between apps which have been correctly optimised for tablets and people which might be merely stretched out telephone apps?
This appears to be an issue from an earlier period, but right here it’s, nonetheless plaguing Android pill house owners in mid-2026.
Jon Mundy / Foundry
Apple’s pill dominance
Suffice to say, Apple doesn’t fear about any of these items. Whereas there are nonetheless situations of cell apps not coming to iPad for a protracted interval – are you able to imagine that WhatsApp solely received a local iPad app final 12 months? – you may usually rely on a large library of correctly iPad-ready functions.
It’s no marvel Apple dominates the pill market, with the iPad collection making up a 51.5% share as of early 2026, in response to StatCounter. And earlier than you say “that’s solely simply over half”, keep in mind the fractured nature of the Android pill, and contemplate the truth that Samsung is in second place with simply 25.8%.
This actually is Apple’s area, and it may take the entire darned factor if it needed.
Who is aware of, perhaps beneath John Ternus’s management, it’s going to. In any case, the newly anointed Apple CEO drove the event of the MacBook Neo, and that’s the product that would level the way in which to a complete pill shutout.
Foundry
Ready for a saviour named Neo
Whereas we usually depart Mac protection to our colleagues at Macworld, we do keep watch over Apple’s laptops – not least as a result of many people select to make use of them for work. Make no mistake, we all know all in regards to the MacBook Neo.
It’s a landmark product from Apple, seeing the corporate lastly dipping its toes into the reasonably priced laptop computer market. The MacBook Neo is a vibrant, vastly accessible, impressively succesful but surprisingly reasonably priced laptop computer that retails for simply £600/$600.
At this value, it enters into the dialog to your common pupil. It’s additionally, not coincidentally, the world of the market by which so many low cost and nasty Home windows laptops function. Frankly, they by no means stood an opportunity.
The subsequent step for Apple appears clear to me: make an iPad Neo and lock up the pill market. Give us a brightly colored £200/$200ish full-sized pill, with Apple’s peerless deal with on the entire software program and {hardware} pipeline, and its spectacular customized silicon operation.
A part of me questions whether or not I needs to be wishing for a digital monopoly to get even stronger, however actually, Google and its Android cohorts solely have themselves responsible. They’ve had 16 years to construct a compelling, constant Android pill ecosystem, however there have been far too many half-steps and false dawns.
Certainly, simply because the MacBook Neo is shaking up the Home windows laptop computer business, an iPad Neo could possibly be simply what the Android pill scene must shake it out of its stupor.